Strides Arcolab completes acquisition of Aspen Pharmacare’s generic pharma business

01 Sep 2015 Evaluate

Pharmaceuticals firm Strides Arcolab has completed Rs 1,910 crore acquisition of Aspen Pharmacare’s generic pharmaceutical business and related assets in Australia. The transaction has now achieved closure on completion of closing conditions and statutory and regulatory approvals. The acquired business will be integrated and consolidated with Strides effective September 1, 2015.

Earlier in may 2015, Strides Arcolab’s subsidiary Strides Pharma Global Pte, Singapore and Strides (Australia) Pharma Pty, Australia signed definitive agreements with certain wholly owned subsidiaries of Aspen Pharmacare Holdings, a company listed on the Johannesburg Stock Exchange (Aspen), to acquire a generic pharmaceutical business in Australia together with certain branded pharmaceutical assets.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

900.65 -39.00 (-4.15%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×